ENTERA BIO LTD. Shares Outstanding
ENTERA BIO LTD. (ENTX) had Shares Outstanding of 49.29 million shares as of 2026-06-30, per its 10-Q filed 2026-08-07.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-07
- 2026-06-30: Shares outstanding (split-adjusted) 49.29M shares; Shares authorized (split-adjusted) 140.01M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 46.62M shares; Shares authorized (split-adjusted) 140.01M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 46.18M shares; Shares authorized (split-adjusted) 140.01M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 45.66M shares; Shares authorized (split-adjusted) 140.01M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 49.29M shares 10-Q · filed 2026-08-07 | 140.01M shares 10-Q · filed 2026-08-07 |
| 2026-03-31 | 46.62M shares 10-Q · filed 2026-05-08 | 140.01M shares 10-Q · filed 2026-05-08 |
| 2025-12-31 | 46.18M shares 10-Q · filed 2026-08-07 | 140.01M shares 10-Q · filed 2026-08-07 |
| 2025-09-30 | 45.66M shares 10-Q · filed 2025-11-14 | 140.01M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 45.45M shares 10-Q · filed 2025-08-08 | 140.01M shares 10-Q · filed 2025-08-08 |
| 2025-03-31 | 45.42M shares 10-Q · filed 2025-05-09 | 140.01M shares 10-Q · filed 2025-05-09 |
| 2024-12-31 | 38.84M shares 10-K · filed 2026-03-27 | 140.01M shares 10-K · filed 2026-03-27 |
| 2024-09-30 | 36.51M shares 10-Q · filed 2024-11-08 | 140.01M shares 10-Q · filed 2024-11-08 |
| 2024-06-30 | 36.31M shares 10-Q · filed 2024-08-09 | 140.01M shares 10-Q · filed 2024-08-09 |
| 2024-03-31 | 35.53M shares 10-Q · filed 2024-05-10 | 140.01M shares 10-Q · filed 2024-05-10 |
| 2023-12-31 | 35.48M shares 10-K · filed 2025-03-28 | 140.01M shares 10-K · filed 2025-03-28 |
| 2023-09-30 | 28.81M shares 10-Q · filed 2023-11-14 | 140.01M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 28.81M shares 10-Q · filed 2023-08-11 | 140.01M shares 10-Q · filed 2023-08-11 |
| 2023-03-31 | 28.81M shares 10-Q · filed 2023-05-05 | 140.01M shares 10-Q · filed 2023-05-05 |
| 2022-12-31 | 28.81M shares 10-K · filed 2024-03-08 | 140.01M shares 10-K · filed 2024-03-08 |
| 2022-09-30 | 28.81M shares 10-Q · filed 2022-11-10 | 140.01M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 28.81M shares 10-Q · filed 2022-08-11 | 140.01M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 28.80M shares 10-Q · filed 2022-05-12 | 140.01M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 28.80M shares 10-K · filed 2023-03-31 | 140.01M shares 10-K · filed 2023-03-31 |
| 2020-12-31 | 21.06M shares 10-K · filed 2022-03-08 | 140.01M shares 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |